Literature DB >> 20422438

Serum resistin concentrations in children with Kawasaki disease.

Hiroki Nozue1, Hironori Imai, Hisako Saitoh, Takeshi Aoki, Kunio Ichikawa, Tomohiro Kamoda.   

Abstract

OBJECTIVE: Human resistin is expressed strongly in monocytes or macrophages rather than in adipocytes and may play a pivotal role in inflammation. We hypothesize that resistin levels are elevated in patients with Kawasaki disease (KD) in the acute phase and may be associated with the disease severity. DESIGN AND
SUBJECTS: Serum resistin concentrations were measured in 44 Japanese children with KD and 17 age-matched healthy children. All the KD patients were given both aspirin and a single dose of intravenous immunoglobulin (IVIG).
RESULTS: The serum resistin levels at baseline in KD children were significantly higher than those in controls [33.0 (21.6-45.3) vs. 14.8 (12.4-18.6) ng/mL, P < 0.001]. After IVIG therapy, serum resistin levels were significantly decreased to normal control levels. No significant difference in baseline resistin levels was found between the high-risk group and the low-risk group of coronary artery aneurysms.
CONCLUSIONS: We confirmed that resistin was an acute inflammatory protein, but its concentrations were unlikely to predict the prognosis of disease in acute KD patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20422438     DOI: 10.1007/s00011-010-0202-8

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  44 in total

1.  NF-kappaB activation in peripheral blood monocytes/macrophages and T cells during acute Kawasaki disease.

Authors:  T Ichiyama; T Yoshitomi; M Nishikawa; M Fujiwara; T Matsubara; T Hayashi; S Furukawa
Journal:  Clin Immunol       Date:  2001-06       Impact factor: 3.969

2.  Evaluation of the cytokine response in Kawasaki disease.

Authors:  B A Eberhard; U Andersson; R M Laxer; V Rose; E D Silverman
Journal:  Pediatr Infect Dis J       Date:  1995-03       Impact factor: 2.129

3.  Relationships between human serum resistin, inflammatory markers and insulin resistance.

Authors:  S Bo; R Gambino; A Pagani; S Guidi; L Gentile; M Cassader; G F Pagano
Journal:  Int J Obes (Lond)       Date:  2005-11       Impact factor: 5.095

4.  Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome.

Authors:  H Kato; S Koike; M Yamamoto; Y Ito; E Yano
Journal:  J Pediatr       Date:  1975-06       Impact factor: 4.406

5.  Dramatic decrease of circulating levels of monocyte chemoattractant protein-1 in Kawasaki disease after gamma globulin treatment.

Authors:  M Terai; T Jibiki; A Harada; Y Terashima; K Yasukawa; S Tateno; H Hamada; S Oana; H Niimi; K Matsushima
Journal:  J Leukoc Biol       Date:  1999-05       Impact factor: 4.962

6.  Plasma resistin levels in patients with type 1 and type 2 diabetes mellitus and in healthy controls.

Authors:  H-C Fehmann; J Heyn
Journal:  Horm Metab Res       Date:  2002 Nov-Dec       Impact factor: 2.936

7.  Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance.

Authors:  Josef V Silha; Michal Krsek; Jan V Skrha; Petr Sucharda; B L G Nyomba; Liam J Murphy
Journal:  Eur J Endocrinol       Date:  2003-10       Impact factor: 6.664

8.  Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction.

Authors:  Subodh Verma; Shu-Hong Li; Chao-Hung Wang; Paul W M Fedak; Ren-Ke Li; Richard D Weisel; Donald A G Mickle
Journal:  Circulation       Date:  2003-07-21       Impact factor: 29.690

9.  Plasma resistin levels in asthmatics as a marker of disease state.

Authors:  Jeffrey Larochelle; John Freiler; John Dice; Larry Hagan
Journal:  J Asthma       Date:  2007-09       Impact factor: 2.515

10.  Proinflammatory cytokine production and insulin sensitivity regulated by overexpression of resistin in 3T3-L1 adipocytes.

Authors:  Yuchang Fu; Liehong Luo; Nanlan Luo; W Timothy Garvey
Journal:  Nutr Metab (Lond)       Date:  2006-07-19       Impact factor: 4.169

View more
  7 in total

1.  Elevated serum resistin in juvenile idiopathic arthritis: relation to categories and disease activity.

Authors:  Tamer A Gheita; Iman I El-Gazzar; Reem I El Shazly; Abeer M Nour El-Din; Enas Abdel-Rasheed; Rasha H Bassyouni
Journal:  J Clin Immunol       Date:  2012-08-11       Impact factor: 8.317

2.  Association between adipokines and coronary artery lesions in children with Kawasaki Disease.

Authors:  Hyun Jung Kim; Eun Hye Choi; Hong Ryang Kil
Journal:  J Korean Med Sci       Date:  2014-10-08       Impact factor: 2.153

3.  Circulating adipokines are associated with Kawasaki disease.

Authors:  Xin-Yan Zhang; Ting-Ting Yang; Xiu-Fen Hu; Yu Wen; Feng Fang; Hui-Ling Lu
Journal:  Pediatr Rheumatol Online J       Date:  2018-05-08       Impact factor: 3.054

4.  Association of circulating resistin and adiponectin levels with Kawasaki disease: A meta-analysis.

Authors:  Xintian Cai; Qing Zhu; Ting Wu; Bin Zhu; Shasha Liu; Shanshan Liu; Xiayire Aierken; Ayguzal Ahmat; Nanfang Li
Journal:  Exp Ther Med       Date:  2019-12-09       Impact factor: 2.447

5.  Adipocytokine profile in children with Kawasaki disease at a mean follow-up period of 5.5 years: A study from North India.

Authors:  Dibya Lochan Praharaj; Amit Rawat; Anju Gupta; Kanika Arora; Rakesh Kumar Pilania; Sagar Bhattad; Surjit Singh
Journal:  World J Clin Pediatr       Date:  2022-07-09

6.  Association of the resistin gene promoter region polymorphism with Kawasaki disease in Chinese children.

Authors:  Ruixi Liu; Bo He; Fang Gao; Qian Liu; Qijian Yi
Journal:  Mediators Inflamm       Date:  2012-04-08       Impact factor: 4.711

7.  Reverse regulation of soluble receptor for advanced glycation end products and proinflammatory factor resistin and S100A12 in Kawasaki disease.

Authors:  Yanqi Qi; Fangqi Gong; Qing Zhang; Chunhong Xie; Wei Wang; Songling Fu
Journal:  Arthritis Res Ther       Date:  2012-11-21       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.